Osteopathology associated with bone resorption inhibitors - Which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature

Journal of Oral Pathology and Medicine

Volumn 42, Issue 8, 2013, Pages 587-593

  Schipmann, S ^a   Metzler, P ^a   Rossle M ^b   Zemann, W ^a   von Jackowski, J ^a   Obwegeser, J A ^a   Gratz K W ^a   Jacobsen, C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Actinomyces; Bone resorption inhibitors; Bony infection; Local risk factor; Osteonecrosis of the jaws

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ACTINOMYCES; ARTICLE; HISTOPATHOLOGY; HUMAN; JAW OSTEONECROSIS; NONHUMAN; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ACTINOMYCES; BONE RESORPTION INHIBITORS; BONY INFECTION; LOCAL RISK FACTOR; OSTEONECROSIS OF THE JAWS;

ACTINOMYCES; ACTINOMYCOSIS; ADULT; AGED; AGED, 80 AND OVER; ALENDRONATE; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOPSY; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; RANK LIGAND; RETROSPECTIVE STUDIES; TOOTH EXTRACTION;

EID: 84883550929     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12038     Document Type: Article

References (42)

1. Hollick R, Reid D. Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties. Menopause Int 2011; 17: 66-72.
2. Basso U, Maruzzo M, Roma A, Camozzi V, Luisetto G, Lumachi F. Malignant hypercalcemia. Curr Med Chem 2011; 18: 3462-7.
3. Hadji P. Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone disease. Crit Rev Oncol Hematol 2011; 80: 301-13.
4. Jin Y, An X, Cai YC, et al. Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2011; 137: 1545-51.
5. Wu S, Dahut WL, Gulley JL. The use of bisphosphonates in cancer patients. Acta Oncol 2007; 46: 581-91.
6. Aapro MS. Denosumab for bone metastases from breast cancer: a new therapy option? J Clin Oncol 2011; 29: e419-20; author reply e421-4.
7. Papapoulos S, Chapurlat R, Libanati C, et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res 2011; [Epub ahead of print].
8. Scott L, Muir V. Denosumab: in the prevention of skeletal-related events in patients with bone metastases from solid tumours. Drugs 2011; 71: 1059-69.
9. Marx R. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-7.
10. Ruggiero SI, Dodson T, Assael L, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009; 67: 2-12.
11. Silverman SI, Landesberg R. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med 2009; 122: S33-45.
12. Adamo V, Caristi N, Saccà MM, et al. Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients. Expert Opin Pharmacother 2008; 9: 1351-61.
13. Jacobsen C, Metzler P, Rossle M, Obwegeser J, Zemann W, Gratz KW. Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Investig 2013; 17: 167-75.
14. Cheng A, Daly C, Logan RM, Stein B, Goss AN. Alveolar bone and the bisphosphonates. Aust Dent J 2009; 54(Suppl 1): S51-61.
15. Marx RE, Cillo JE, Ulloa J. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007; 65: 2397-410.
16. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 2007; 41: 318-20.
17. Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 2006; 7: 508-14.
18. Reid IR. Osteonecrosis of the jaw: who gets it, and why? Bone 2009; 44: 4-10.
19. Biasotto M, Chiandussi S, Dore F, et al. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws. Acta Odontol Scand 2006; 64: 348-54.
20. Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol 2008; 63: 71-7.
21. Hansen T, Kunkel M, Springer E, et al. Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007; 451: 1009-17.
22. Hansen T, Kunkel M, Weber A, James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 2006; 35: 155-60.
23. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg 2009; 67: 850-5.
24. Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 2004; 117: 440-1.
25. Hall V. Actinomyces-gathering evidence of human colonization and infection. Anaerobe 2008; 14: 1-7.
26. Kaplan I, Anavi K, Anavi Y, et al. The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 738-46.
27. Kos M. Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation. Med Hypotheses 2011; 1-2.
28. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery 2011; 38: 255-9.
29. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 2005; 34: 613-7.
30. Ruggiero S. Bisphosphonate-related osteonecrosis of the jaws. Compend Contin Educ Dent 2008; 29: 96-8, 100-2, 104-5.
31. Saia G, Blandamura S, Bettini G, et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg 2010; 68: 797-804.
32. Vescovi P, Campisi G, Fusco V, et al. Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol 2011; [Epub ahead of print].
33. Junquera L, Gallego L. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg 2008; 66: 1516-7.
34. Kassolis JD, Scheper M, Jham B, Reynolds MA. Histopathologic findings in bone from edentulous alveolar ridges: a role in osteonecrosis of the jaws? Bone 2010; 47: 127-30.
35. Sedghizadeh PP, Kumar SKS, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. Journal of the American Dental Association (1939) 2009; 140: 1259-65.
36. Blinkhorn RJ, Strimbu V, Effron D, Spagnuolo PJ. 'Punch' actinomycosis causing osteomyelitis of the hand. Arch Intern Med 1988; 148: 2668-70.
37. Honda H, Bankowski MJ, Kajioka E, Chokrungraranon N, Kim W, Gallacher ST. Thoracic vertebral actinomycosis: Actinomyces israelii and Fusobacterium nucleatum. J Clin Microbiol 2008; 46: 2009-14.
38. Lipton M, Sonnenfeld G. Actinomyces meyeri osteomyelitis: an unusual cause of chronic infection of the tibia. Clin Orthop Relat Res 1980; 148: 169-71.
39. Long JB, Collins JM, Beauchamp C, Kho R, Cornella J. Actinomyces meyeri osteomyelitis of the symphysis pubis following pubovaginal sling. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 1375-8.
40. Pinilla I, Martín-Hervás C, Gil-Garay E. Primary sternal osteomyelitis caused by Actinomyces israelii. South Med J 2006; 99: 96-7.
41. Robinson JL, Vaudry WL, Dobrovolsky W. Actinomycosis presenting as osteomyelitis in the pediatric population. Pediatr Infect Dis J 2005; 24: 365-9.
42. Kos M, Brusco D, Kuebler J, Engelke W. Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration. Int J Oral Maxillofac Surg 2010; 39: 1097-102.